Avadel Pharmaceuticals

NASDAQ: AVDL · Real-Time Price · USD
9.74
0.30 (3.18%)
At close: Jun 06, 2025, 3:59 PM
9.72
-0.21%
After-hours: Jun 06, 2025, 04:04 PM EDT

Avadel Pharmaceuticals Revenue

Avadel Pharmaceuticals reported an annual revenue of $169.12M, reflecting a 504.79% growth. For the quarter ending March 31, 2025, Avadel Pharmaceuticals generated $52.51M in revenue.
Revenue (ttm)
$169.12M
Revenue Growth
504.79%
Price / Sales Ratio
5.91
Revenue / Employee
$899.56K
Employees
188
Market Cap
942.24M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.